COMMUNIQUÉS West-GlobeNewswire

Rani Therapeutics to Participate in August Investor Conferences

29/07/2024 - 22:05

SAN JOSE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

29/07/2024 - 22:05

Southlake, TX, July 29, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology [...]

IMUNON to Report Topline Results from the Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian Cancer Tomorrow

29/07/2024 - 22:05

Results to be announced at 8:00 a.m. Eastern time, conference call to begin at 8:30 a.m. Eastern time LAWRENCEVILLE, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN ), a clinical-stage company in late [...]

Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China

29/07/2024 - 22:05

Primary and Secondary Endpoints Achieved with Favorable Tolerability and Safety Profile ALPHARETTA, Ga., July 29, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company [...]

Maravai LifeSciences Appoints Trey Martin to Board of Directors

29/07/2024 - 22:05

Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Maravai [...]

T2 Biosystems Announces Second Quarter 2024 Financial Results

29/07/2024 - 22:05

Achieved record quarterly and first half sepsis test revenue, representing growth of 27% and 25% respectively compared to the prior year periods LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. ( [...]

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

29/07/2024 - 22:05

MENLO PARK, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, [...]

NurExone Announces Further Expansion of ExoPTEN Patent Coverage

29/07/2024 - 22:04

TORONTO and HAIFA, Israel, July 29, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company developing [...]

T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor

29/07/2024 - 22:02

LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a [...]

Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024

29/07/2024 - 22:01

SAN CARLOS, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating [...]

Celldex Therapeutics Presents Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Inducible Urticaria

29/07/2024 - 22:01

Met primary endpoint demonstrating clinically meaningful and statistically significant complete response rate across both dose groups First large, randomized, placebo-controlled study to demonstrate success in CIndU [...]

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti

29/07/2024 - 22:00

Proposed acquisition adds novel macroporous chromatography base bead technology for downstream bioprocess applications Accelerates expansion into new modality markets with a unique, scalable purification solution [...]

SAFE - Lancement d’un regroupement d’actions Safe

29/07/2024 - 19:25

Lancement d’un regroupement d’actions Safe 3.000 actions anciennes contre 1 action nouvelle Mise en œuvre des opérations de regroupement à compter du 14 août 2024 Premier jour de cotation des actions regroupées le 16 [...]

Fairway Consulting Group Recognized as a Top 40 Life Sciences Executive Search Firm by Hunt Scanlon

29/07/2024 - 19:02

NEW YORK, July 29, 2024 (GLOBE NEWSWIRE) -- Fairway Consulting Group (FCG) , a leading executive search firm focused on providing outstanding talent solutions for the pharmaceutical, biotechnology, diagnostic, and [...]

SAFE - COMPTE-RENDU DE L’ASSEMBLEE GENERALE EXTRAORDINAIRE DU 26 JUILLET 2024

29/07/2024 - 18:15

COMPTE-RENDU DE L’ASSEMBLEE GENERALE EXTRAORDINAIRE DU 26 JUILLET 2024 Fleurieux-sur-l’Arbresle - France - le 29 juillet 2024 à 18h15 . L’Assemblée Générale Extraordinaire des actionnaires de Safe (FR001400F1V2 – ALSAF [...]

SAFE - FIRST-HALF 2024 SALES

29/07/2024 - 18:00

FIRST-HALF 2024 SALES Fleurieux-sur-l’Arbresle - France - July 29, 2024, 6.00 p.m. The group Safe (FR001400F1V2 – ALSAF) announces consolidated sales for 1st half 2024. In k€ First-half 2024* First-half 2023 % change [...]

SAFE - CHIFFRE D’AFFAIRES DU 1ER SEMESTRE 2024

29/07/2024 - 18:00

CHIFFRE D’AFFAIRES DU 1 ER SEMESTRE 2024 Fleurieux-sur-l’Arbresle - France - le 29 juillet 2024 à 18h . Safe (FR001400F1V2 – ALSAF) annonce son chiffre d’affaires consolidé sur le 1 er semestre 2024. En k€ S1 2024* S1 [...]

Orchid Launches the First HIPAA-Compliant AI-Powered Clinical Notes Solution for Mental Health Clinicians - Integrates With Any EHR To Help Automate Note Taking and Free Up Time for Patient Care

29/07/2024 - 17:25

Orchid’s AI reduces clinical note writing from 20 minutes down to a few seconds per session WILMINGTON, Del., July 29, 2024 (GLOBE NEWSWIRE) -- Orchid , the first and only AI-powered EHR for mental health, announced [...]

Zealand Pharma Appoints Eric Cox as Chief Commercial Officer

29/07/2024 - 17:00

Press release – 7 / 2024 Zealand Pharma Appoints Eric Cox as Chief Commercial Officer Copenhagen, Denmark, 29 July 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused [...]